A bubble heatmap depicted the connection between common agents treating MM and gene expression in Figure 4D. UBE2D1 conferred bortezomib resistance while CUL1, PSMC2, and UBE2B were sensitive to BTZ. The gene discussed is UBE2D1; the disease is Miyoshi myopathy.